Form 4: IonQ CFO Sells Shares Under 10b5-1 Plan

IonQ's Chief Financial Officer, Thomas G. Kramer, sold 17,776 shares of common stock for approximately $41.28 per share under a pre-arranged trading plan.

Summary

• IonQ's Chief Financial Officer, Thomas G. Kramer, sold 17,776 shares of common stock.
• The sale occurred on August 6, 2025, at a weighted average price of $41.2804 per share.
• Individual sale prices ranged from $40.88 to $43.00.
• The transaction was executed under a Rule 10b5-1 trading plan adopted on March 14, 2025.
• Following the sale, Mr. Kramer directly owns 537,880 shares and indirectly owns 5 shares through a child, totaling 537,885 shares.

Sentiment

Score: 5

Explanation: Neutral. The sale is a routine insider transaction under a pre-arranged 10b5-1 plan, which mitigates negative sentiment often associated with executive share sales. It does not indicate a change in company fundamentals or outlook.

Positives

• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating it was not a discretionary sale based on new, non-public information.

Negatives

• A significant sale of shares by a key executive, even if pre-planned, can sometimes be perceived negatively by investors as it reduces the executive's direct stake in the company.

Future Outlook

NA

Industry Context

This Form 4 filing reports an insider transaction for IonQ, a company operating in the quantum computing industry. Such filings are routine disclosures and do not typically reflect broader industry trends, though they provide insight into executive compensation and portfolio management within the sector.

Stakeholder Impact

• Shareholders: The sale by a key executive, even if pre-planned, might be viewed with slight caution, but the 10b5-1 plan mitigates concerns about insider sentiment. It does not directly impact employees, customers, suppliers, or creditors.

Key Dates

Recommendation

The filing is a routine insider transaction (Form 4) reporting a pre-scheduled sale by the CFO under a 10b5-1 plan. This type of transaction is generally not indicative of a change in the company's fundamental outlook or performance. Therefore, it does not provide new information that would warrant a change in investment recommendation. A 'hold' recommendation is appropriate as the filing itself does not present new reasons to buy or sell.

Keywords

IonQ, IONQ, Thomas G. Kramer, CFO, Form 4, Insider Trading, Share Sale, 10b5-1 Plan, Quantum Computing